High cost drugs - Tildrakizumab
Codelist metadata
-
Coding system
- No coding system
-
Coding system release
- unknown
-
Organisation
- OpenSAFELY
-
Codelist ID
- opensafely/high-cost-drugs-tildrakizumab
-
Version ID
- 7c6a5183
Versions
About
Description
This is a list of all the unique values from the Drug Name variable in the High Cost Drugs Dataset that relate to the prescribing of tildrakizumab.
Methodology
The values in this variable do not follow a coding system so the selection for this codelist is based on the drug name value, after converting all text to lower case, containing one or more of the following strings (these are the generic medicine name and brand names):
- tildrakizumab
- ilumetri
All drug name values that contain at least one of the above strings are included in the tildrakizumab group and assigned the VTM (virtual therapeutic moiety) code 36440811000001104.
References
Signed off by
- Mark Yates, (Feb. 26, 2021)
- Nick Kennedy, (Feb. 26, 2021)
- Anna Rowan, (Feb. 26, 2021)
- Sinéad langan, (Feb. 26, 2021)
- James Galloway, (Feb. 26, 2021)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| olddrugname |
|---|
| homecare tildrakizumab |
| tildrakizumab |
| tildrakizumab (homecare) |